MCGRATH YVONNE (VP, Research and Development) sold 10K shares of ITEOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $367.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2022ACC: 0001209191-22-015080
Officer· VP, Research and Development
Since Jul 2020
-10K
Net shares
Net seller
$367.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$4.24
Trade value
$42.40K
% of position
New position
3/1/2022
0.00→10K
Common Stock
Direct
Shares
−10K
Price / share
$36.76
Trade value
$367.57K
% of position
New position
3/1/2022
10K→0.00
Total
Net shares
+0.00
Net value
-$325.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2022 | M · Option Exercise | +10K | $4.24 | $42.40K | New position | 0.00 | 10K |
| Common Stock Direct | 3/1/2022 | S · Sale | −10K | $36.76 | $367.57K | New position | 10K | 0.00 |
| Total | +0.00 | -$325.17K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
4.24
Held after
85.12K
Exercisable
—
3/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 3/1/2022 | M · Option Exercise | −10K | 4.24 | — | 85.12K |